<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 04 Aug 2026 16:51:24 -0400--><rss version="2.0">
    <channel>
        <title>Stevanato Group S.p.A. (STVN) Press Releases</title>
        <link>https://ir.stevanatogroup.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/stevanatogroup/files/theme/images/logo-sm.png</url>
                <title>Stevanato Group S.p.A. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/183/stevanato-group-delivers-8-revenue-growth-for-the-second</link>
                <pubDate>Tue, 04 Aug 26 06:30:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/183/stevanato-group-delivers-8-revenue-growth-for-the-second</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/182/liraglutide-combination-products-incorporating-stevanato</link>
                <pubDate>Thu, 30 Jul 26 06:30:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/182/liraglutide-combination-products-incorporating-stevanato</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/181/stevanato-group-to-report-second-quarter-2026-financial</link>
                <pubDate>Tue, 21 Jul 26 06:30:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/181/stevanato-group-to-report-second-quarter-2026-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/180/stevanato-group-introduces-deora-a-pen-injector-for</link>
                <pubDate>Mon, 08 Jun 26 06:30:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/180/stevanato-group-introduces-deora-a-pen-injector-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/179/stevanato-group-announces-results-of-ordinary-and</link>
                <pubDate>Wed, 03 Jun 26 17:45:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/179/stevanato-group-announces-results-of-ordinary-and</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/178/stevanato-group-delivers-7-revenue-growth-10-at-constant</link>
                <pubDate>Thu, 07 May 26 06:30:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/178/stevanato-group-delivers-7-revenue-growth-10-at-constant</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group to Participate in Three Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/177/stevanato-group-to-participate-in-three-upcoming-investor</link>
                <pubDate>Mon, 04 May 26 17:45:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/177/stevanato-group-to-participate-in-three-upcoming-investor</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/176/stevanato-group-to-report-first-quarter-2026-financial</link>
                <pubDate>Thu, 23 Apr 26 16:05:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/176/stevanato-group-to-report-first-quarter-2026-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/175/stevanato-group-to-participate-in-the-keybanc-capital</link>
                <pubDate>Thu, 12 Mar 26 16:45:00 -0400</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/175/stevanato-group-to-participate-in-the-keybanc-capital</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.stevanatogroup.com/news-events/press-releases/detail/174/stevanato-group-delivers-7-revenue-growth-9-at-constant</link>
                <pubDate>Wed, 04 Mar 26 06:30:00 -0500</pubDate>
                <guid>https://ir.stevanatogroup.com/news-events/press-releases/detail/174/stevanato-group-delivers-7-revenue-growth-9-at-constant</guid>
                                                                            </item>
            </channel>
</rss>